Currently Viewing:
Community Oncology Alliance
Rose Gerber's Outlook on the Evolution and Goals of COA'S CPAN
July 13, 2017
Dr Barbara McAneny Discusses the Continuing Evolution of the COME HOME Model
July 07, 2017
Dr Basit Chaudhry on the Impact of the Oncology Care Model
July 05, 2017
Rose Gerber Discusses Cancer Survivorship's Lifelong Side Effects
June 30, 2017
Dr Bobby Green Explains How Changing Oncology Landscape Drives Big Data Initiatives
June 23, 2017
Currently Reading
Leah Ralph on the Political and Legal Obstacles to 340B Reform
June 20, 2017
Dr Daniel George on the Challenge of Cancer Vaccines
May 04, 2017
Big Data Is Advancing Cancer Care, but Interoperability Remains a Challenge
May 03, 2017
Leah Ralph on ACCC's Concerns With GOP Healthcare Reform Proposals
April 30, 2017
Linking Claims, Clinical Data Is Essential for a Learning Health System
April 28, 2017
Dr Basit Chaudhry: Feedback Provides Potential Changes for the OCM
April 28, 2017
Christian Downs on the Importance of Developing the Oncology Workforce
April 28, 2017
Oncologists Believe Achieving Cancer Moonshot Goals Should Start in the Community
April 28, 2017
Oncology Practice Administrators Discuss Early Findings From the OCM
April 27, 2017
Rose Gerber: Cancer Patients Made Their Voices Heard on Capitol Hill
April 27, 2017
Congressman, Pharmacist, and Lawyer Debate PBMs, Drug Prices at Annual COA Meeting
April 27, 2017
Dr Barbara McAneny on Leveling the Playing Field for Community Oncology
April 27, 2017

Leah Ralph on the Political and Legal Obstacles to 340B Reform

The uncertainty in the political climate, along with the limited authority of the Health Resources and Services Administration within HHS, makes it difficult to predict whether the 340B program will be reformed in coming years, according to Leah Ralph, director of health policy at the Association of Community Cancer Centers.


The uncertainty in the political climate, along with the limited authority of the Health Resources and Services Administration (HRSA) within HHS, makes it difficult to predict whether the 340B program will be reformed in coming years, according to Leah Ralph, director of health policy at the Association of Community Cancer Centers.

Transcript (slightly modified)

There are many healthcare programs that rely on funding from 340B. Given this, what hope is there for real reform in 2017/2018?

The current political environment creates a lot of uncertainty around when or if we will see some comprehensive reform on the 340B program. This is something that people have been calling for, for a long time, to really fundamentally revisit the program and understand the reach that it is having, the patients that it’s serving, and the purpose of the program.

We’ve seen HRSA attempt to kind of put some parameters around the program with the mega-guidance that they had recently released. In January, that rule was actually pulled back, largely more so because of the Trump administration’s regulatory review effort, as a new administration does when they come to the White House.

I think it’s a challenging issue, and it’s hard to see a path forward on what policy maker is able to fundamentally make some of those changes. Again, in the mega-guidance we did see this effort to tighten the definition of a patient that would be eligible for discounted 340B drugs. I think in some ways the guidance was trying to please both sides, and in an effort maybe not both sides weren’t entirely happy, and they’re also limited in their authority.

They’ve been really strictly limited in the legal authority that they have to regulate around the program, which is why we’re seeing things like guidance and not regulations, so it’s unclear what the path forward is on that. I think that’s another example of, if the administration is as interested in drug pricing reform as some of the tweets that we’ve seen from the president, that may be part of a broader effort, but I think it’s going to need to be part of a broader vehicle to get anything accomplished.

 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!